These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38099987)

  • 1. Correction: A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
    Zhou B; Cheng L; Pan J; Wang H; Jin Y; Zhao C; Lin P; Tan G; Fang H; Zhang H; Zhou H; Dong Y; Kuhl HC; Ramalingam RK; Nguyen DT
    Pulm Ther; 2024 Mar; 10(1):143-144. PubMed ID: 38099987
    [No Abstract]   [Full Text] [Related]  

  • 2. A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
    Zhou B; Cheng L; Pan J; Wang H; Jin Y; Zhao C; Lin P; Tan G; Fang H; Zhang H; Zhou H; Dong Y; Kuhl HC; Ramalingam RK; Nguyen DT
    Pulm Ther; 2023 Sep; 9(3):411-427. PubMed ID: 37580498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal spray medications for maintenance therapy of allergic rhinitis.
    Berger WE; Meltzer EO
    Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
    Ilyina NI; Edin AS; Astafieva NG; Lopatin AS; Sidorenko IV; Ukhanova OP; Khanova FM
    Int Arch Allergy Immunol; 2019; 178(3):255-263. PubMed ID: 30677766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
    Berger W; Meltzer EO; Amar N; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Bousquet J
    Pediatr Allergy Immunol; 2016 Mar; 27(2):126-33. PubMed ID: 26928753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
    Kaulsay R; Nguyen DT; Kuhl HC
    Immun Inflamm Dis; 2018 Dec; 6(4):456-464. PubMed ID: 30306729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of in vitro Penetration of Fluticasone Propionate from MP-AzeFlu and Fluticasone Propionate Nasal Spray Through EpiAirway™606 Tissues Using Vertical Diffusion Cells.
    Berger WE; Bachert C; Allara R; Koltun A; Kopietz F; Maus JG; D'Addio AD
    J Asthma Allergy; 2020; 13():187-192. PubMed ID: 32547111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
    Scadding G; Price D; El-Shanawany T; Ahmed S; Ray J; Sargur R; Kumar N
    BMJ Open; 2017 Apr; 7(4):e014777. PubMed ID: 28442578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and safety of MP-AzeFlu for the treatment of allergic rhinitis: a meta-analysis.
    Zhong Z; Xun Y; Shi X; Guan B; Wang M
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2457-2464. PubMed ID: 34415405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review.
    Klimek L; Berger WE; Bousquet J; Keith PK; Smith P; Sole D; Scadding G; Kuhl HC; Nguyen DT; Kopietz F; Koltun A
    Int Arch Allergy Immunol; 2021; 182(11):1026-1035. PubMed ID: 34082425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity.
    Meltzer EO; Bachert C; Mayer MJ; Kopietz F; Koltun A; Maus J; D'Addio AD
    Allergy Asthma Proc; 2020 Jul; 41(4):265-270. PubMed ID: 32393418
    [No Abstract]   [Full Text] [Related]  

  • 13. The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers.
    Qi W; Liu Y; Xue W; Li K; Gorski JC; Liu M; Yan T; Nguyen DT; Ramalingam RK
    J Asthma Allergy; 2023; 16():667-677. PubMed ID: 37409000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber.
    Bousquet J; Meltzer EO; Couroux P; Koltun A; Kopietz F; Munzel U; Kuhl HC; Nguyen DT; Salapatek AM; Price D
    J Allergy Clin Immunol Pract; 2018; 6(5):1726-1732.e6. PubMed ID: 29425904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children.
    Berger W; Bousquet J; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Wahn U
    Allergy; 2016 Aug; 71(8):1219-22. PubMed ID: 27043452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Azelastine Hydrochloride/Fluticasone Propionate in the Management of Allergic Rhinitis in Asia: A Review.
    Tantilipikorn P; Kirtsreesakul V; Bunnag C; Vangveeravong M; Thanaviratananich S; Chusakul S
    J Asthma Allergy; 2024; 17():667-679. PubMed ID: 39045291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US.
    Prenner BM
    J Asthma Allergy; 2016; 9():135-43. PubMed ID: 27468241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Effects of Azelastine and Fluticasone Nasal Sprays in the Treatment of Allergic Rhinitis.
    Krishnakumar D; Faizal B; Nair AS
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):1632-1637. PubMed ID: 36452604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers.
    Roca-Ferrer J; Pujols L; Pérez-González M; Alobid I; Callejas B; Vicens-Artés S; Fuentes M; Valero A; Picado C; Castor D; Nguyen D; Mullol J
    Allergy Asthma Clin Immunol; 2018; 14():86. PubMed ID: 30574167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-Life Effectiveness of MP-AzeFlu (Dymista
    Stjärne P; Nguyen DT; Kuhl HC
    Pragmat Obs Res; 2023; 14():1-11. PubMed ID: 36628265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.